From science to medicine. An uncertain step: Lessons from CD34+ cell selection devices;LE TRANSFERT INCERTAIN DE LA SCIENCE VERS LA MEDECINE: L'EXEMPLE DES SYSTEMES DE SELECTION DE CELLULES CD34+

Medecine/Sciences

Volumn 14, Issue 2, 1998, Pages 183-187

  Chabannon, Christian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MONOCLONAL ANTIBODY;

ALLOGRAFT; AUTOGRAFT; BIOTECHNOLOGY; CELL SELECTION; CELL SORTER; HEALTH CARE COST; HEMATOPOIETIC STEM CELL; IMMUNOADSORPTION; MEDICINE; REVIEW; SCIENCE;

MURINAE;

EID: 0031964264     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1006     Document Type: Review

References (32)

1. Department of Health and Human Services. Food and Drug Administration. Center for Biological Evaluation and Research. Biological Response Modifiers Advisory Committee Nineteenth Meeting. Bethesda, MA : July 24, 1997.
2. Civin CI, Trischmann T, Kadan NS, Davis J, Noga S, et al. Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol 1996 ; 14 : 2224-33.
3. + cells for hematologic rescue of advanced breast cancer patients treated with high-dose chemotherapy. Proc Am Assoc Cancer Res 1996; 37 : 176 (abstr.).
4. + peripheral blood stem cells for autografting in patients with breast cancer. Brit J Haematol 1997; 97 : 881-8.
5. Mapara M, Körner IJ, Hildebrandt M, Bergou R, Krahl D, Reichardt P, Dörken B. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polytnerase chain reaction. Blood 1997 ; 89 : 337-44.
6. Chabannon C, Mannont P. Les cellules souches hématopoiétiques du sang périphérique chez l'homme. Med Sa 1995; 11 :17-27.
7. Greaves MF, Titley I, Colman SM, Bühring HJ, Campos L, et al. CD34 cluster workshop report. In : Schlossman SF, Bounisell L, Gilks W, eds. Ieskocyte typing V. White Cell differentiation antigens, vol. 1. Oxford : Oxford University Press, 1995 : 840-6.
8. Krause D, Fackler MJ, Civin CI, May WS. Blood CD34: structure, biology, and clinical utility. Blood 1996 ; 87 : 1-13.
9. Cheng J, Baumhueter S, Cacalano G, Carver-Moore K, Thibodeaux H, Thomas R, Broxmeyer HE, Cooper S, Hague N, Moore M, Lasky LA. Hematopoietic defects in mice lacking the sialomucm CD34. Blond 1996 ; 87 : 479-90.
10. Osawa M, Hanada KI, Hamada H, Nakauchi H. Long-term lymphohemato-poietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996 ; 273 : 242-5.
11. Weissman IL, Morrison S, Cheshier S, Uchida N. Hematopoietic stem cells: biology and transplantation. Exp Hematol 1997 ; 25 : 727 (abstr.).
12. + blood cells, Blood 1996 ; 87 : 4903-9.
13. Bensinger WI, Buckner CD, Shannon-Dorcy K, Rowley S, Appelbanm FR, et al. Transplantation of allogeneic CD34: peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1997 : 88 : 4132-8.
14. Civin CL, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shapei JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-Ia cells. J Immunol 1984 ; 133 : 157-65.
15. Shpall E, Jones R, Bearman SI, Franklin WA, Archer PG, et al. Transplantation of enriched CD34-positive aulologous marrow into breast cancer patients following high-dose chemotherapy : influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 1994 ; 12 : 28-36.
16. Brugger W, Henschler R, Heimfeld S, Berenson RJ, Mertelsmann R, Kamz L. Positively selected autologous blood CD34' cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994 ; 84 : 1421-6.
17. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 1995 ; 86 : 1647-54.
18. Schiller G, Vescio R, Freytes C, Spirze G, Sahebi F. et al. Transplantation of CD34' peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 96 : 390-7.
19. Shpall EJ, Le Maistre CF, Holland K, Ball E, Jones RB, et al. A prospective randomized trial of buffy coat versus CD34-selected auto logons bone marrow support in high risk breast cancer patients receiving high-dose chemotherapy. Blood. 1997 ; 90 : 4313-20.
20. + cells to remove circulating tumor cells. Blood 1996 ; 87 : 1625-34.
21. + cells for positive selection in newly diagnosed patients with myeloma and lymphoma. Brit J Haematol 1996 ; 92 : 263-8.
22. + peripheral blood stem cell transplants for follicular lymphoma : a pilot study. J Clin Oncol 1997 ; 15 : 2288-95.
23. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Anderseon WF. Ihle JN. Genemarking to trace origin of relapse after autologous bone marrow transplantation. Lancet 1993 ; 341 : 85-6.
24. + cells present in autologous transplants of chronic inyelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994 ; 83 ; 3068-70.
25. Tiberghien P, Cahn J, Hervé P Modulation de la réactivité allogénique après la greffe de cellules souches hématopoïétiques. Med Sci 1997 ; 13 : 312-22.
26. Department of Health and Human Services. Food and drug administration. Center for biological evaluation and research. Biological response modifiers advisory committee. Bethesda, MD : February 28, 1996.
27. Andrews R, Singer JW, Bernstein ID. Monoclonal antibody 12.8 recognizes a 115Kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors, Blood 1986 ; 67 : 842-5.
28. Berenson RJ, Bensinger WI, Kalamasz D. Positive selection of viable cell populations using avidin-biotin immunoadsorption. J Immunol Meth 1986 ; 91 : 11-9.
29. Miltenyi S, Muller W, Weichel W, Radbruch A. High gradient magnetic separation with MACS. Cytometry 1990 ; 11 : 231-8.
30. + cells using the Amgen Cell Selection Device results in high levels of purity and recovery. J Hematother 1997 ; 6 : 5-11.
31. + cells isolated with the Amgen cell selector provide rapid engraftment following high-dose chemotherapy in breast cancer patients. Blood 1996 ; 88 : (suppl 1), 110a (abstr.).
32. + hematopoietic stem cells - purging of human tumor cells. Transplantation 1992 ; 53 : 1011-9.